• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 4-(3-Trifluoromethoxyphenyl)benzoic Acid (CAS No. 1093758-81-6) and Its Emerging Applications in Chemical Biology and Medicine

4-(3-Trifluoromethoxyphenyl)benzoic acid, identified by the chemical abstracts service number CAS No. 1093758-81-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and chemical biology. This compound belongs to the benzoic acid derivatives class, characterized by its unique structural features, including a trifluoromethoxy substituent on the phenyl ring. The presence of this fluorinated group enhances its pharmacological properties, making it a valuable candidate for drug discovery and development.

The structural motif of 4-(3-Trifluoromethoxyphenyl)benzoic acid consists of a benzoic acid core linked to a phenyl ring via an ester or amide bond, with the trifluoromethoxy group (-OCH?CF?) positioned at the 3-position of the phenyl ring. This configuration imparts distinct electronic and steric properties, influencing its interactions with biological targets. The trifluoromethoxy group, in particular, is known for its ability to modulate lipophilicity and metabolic stability, which are critical factors in drug design.

In recent years, 4-(3-Trifluoromethoxyphenyl)benzoic acid has been extensively studied for its potential applications in medicinal chemistry. Its derivatives have been explored as inhibitors of various enzymes and receptors involved in metabolic diseases, inflammation, and cancer. The compound's ability to selectively interact with biological targets makes it a promising scaffold for developing novel therapeutic agents.

One of the most compelling aspects of 4-(3-Trifluoromethoxyphenyl)benzoic acid is its role in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer. Researchers have synthesized various derivatives of this compound to target specific kinases, such as Janus kinases (JAKs) and tyrosine kinases (Tyrosine Kinase Inhibitors - TKIs). These derivatives have shown promising preclinical activity in inhibiting tumor growth and reducing inflammation.

Furthermore, 4-(3-Trifluoromethoxyphenyl)benzoic acid has been investigated for its potential in treating neurological disorders. The compound's ability to cross the blood-brain barrier and interact with central nervous system (CNS) targets has made it an attractive candidate for developing treatments for conditions such as Alzheimer's disease and Parkinson's disease. Preliminary studies suggest that certain derivatives of this compound can modulate neurotransmitter release and protect against neurodegeneration.

The pharmaceutical industry has also explored 4-(3-Trifluoromethoxyphenyl)benzoic acid as a starting material for synthesizing more complex molecules with enhanced pharmacological properties. By modifying the substituents on the benzoic acid core or introducing additional functional groups, researchers can fine-tune the activity and selectivity of these compounds. This approach has led to the discovery of several novel drug candidates that are currently undergoing clinical evaluation.

Another area where 4-(3-Trifluoromethoxyphenyl)benzoic acid has shown promise is in the field of anti-inflammatory drugs. Chronic inflammation is a hallmark of many diseases, including arthritis, cardiovascular disease, and autoimmune disorders. Derivatives of this compound have been found to inhibit key inflammatory pathways by suppressing the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6).

The use of computational methods, such as molecular docking and virtual screening, has further accelerated the discovery process for 4-(3-Trifluoromethoxyphenyl)benzoic acid derivatives. These techniques allow researchers to predict the binding affinity of potential drug candidates to biological targets with high accuracy. By integrating experimental data with computational models, scientists can rapidly identify promising compounds for further development.

In conclusion,4-(3-Trifluoromethoxyphenyl)benzoic acid (CAS No. 1093758-81-6) is a versatile compound with significant potential in pharmaceutical research and chemical biology. Its unique structural features make it an excellent scaffold for developing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development.

• 728919-11-7(4'-TRIFLUOROMETHOXY-BIPHENYL-4-CARBOXYLIC ACID)
• 1215206-30-6(3'-(Trifluoromethoxy)biphenyl-3-carboxylic acid)
• 1014-81-9(3-(Trifluoromethoxy)benzoic acid)
• 1258632-82-4(5-Hydroxy-3-(3-trifluoromethoxyphenyl)benzoic acid)
• 916420-51-4(3-Methyl-5-(trifluoromethoxy)benzoic acid)
• 1261657-84-4(3-Methyl-4-(3-trifluoromethoxyphenyl)benzoic acid)
• 1261560-31-9(3-Methyl-4-(4-trifluoromethoxyphenyl)benzoic acid)
• 1261657-08-2(5-Methoxy-3-(3-trifluoromethoxyphenyl)benzoic acid)
• 1261831-45-1(5-Methoxy-3-(4-trifluoromethoxyphenyl)benzoic acid)
• 728919-12-8(4'-Trifluoromethoxybiphenyl-3-carboxylic Acid)